Georgia Man Claims Zantac Caused His Stage 3 Colon Cancer

By Mike Curley (April 23, 2020, 8:03 PM EDT) -- A Georgia man sued Sanofi-Aventis US LLC and Boehringer Ingelheim Pharmaceuticals Inc. in a proposed class action in federal court on Thursday, alleging his use of the heartburn drug Zantac caused his stage 3 colon cancer.

Robert R. Pagniello told the court Sanofi and Boehringer deliberately hid the presence of a known carcinogen in Zantac, and he unknowingly took it for five years before he was diagnosed in January 2019.

In the complaint, Pagniello says he is still being treated for cancer and has incurred more than $600,000 in hospital bills for treatment.

The suit comes three weeks after the Food...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!